Significant association of BRCA1 (rs1799950), BRCA2 (rs144848) and TP53 (rs1042522) polymorphism with breast cancer risk in Pashtun population of Khyber Pakhtunkhwa, Pakistan

被引:4
|
作者
Khan, Yumna [1 ]
Khan, Najeeb Ullah [1 ]
Ali, Ijaz [2 ]
Khan, Samiullah [3 ]
Khan, Aakif Ullah [3 ]
Iqbal, Aqib [1 ]
Adams, Brian D. [4 ]
机构
[1] Univ Agr, Inst Biotechnol & Genet Engn, Hlth Div, Peshawar, Pakistan
[2] Gulf Univ Sci & Technol, Ctr Appl Math & Bioinformat CAMB, Hawally, Kuwait
[3] Inst Radiotherapy & Nucl Med IRNUM, Peshawar, Pakistan
[4] Brain Inst Amer, Dept RNA Sci, New Haven, CT 06511 USA
关键词
Breast cancer; Risk association; BRCA1; BRCA2; TP53; Polymorphisms; P53; CODON-72; POLYMORPHISM; OVARIAN-CANCER; PATHOLOGICAL CHARACTERISTICS; PROGESTERONE-RECEPTOR; ESTROGEN-RECEPTOR; MUTATIONS; VARIANTS; SUSCEPTIBILITY; CARCINOMA; FREQUENCY;
D O I
10.1007/s11033-023-08463-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BackgroundSingle nucleotide polymorphism (SNPs) in BRCA1, BRCA2 and TP53 has been widely associated with breast cancer risk in different ethnicities with inconsistent results. There is no such study conducted so far in the Pashtun population of Khyber Pakhtunkhwa, Pakistan. Therefore, this study was conducted to check BRCA1 (rs1799950), BRCA2 (rs144848) and TP53 (rs1042522) polymorphism with breast cancer risk in Pashtun population of Khyber Pakhtunkhwa, Pakistan.MethodsThis study, consisting 140 breast cancer patients and 80 gender and age matched healthy controls were subjected to confirm BRCA1, BRCA2 and TP53 polymorphism. Clinicopathological data and blood samples were taken from all the participants. DNA was extracted and SNPs were confirmed using T-ARMS-PCR protocol.ResultsOur data indicated that BRCA1, BRCA2, and TP53 selected SNPs risk allele and risk allele containing genotypes displayed significant association (p < 0.05) with breast cancer risk in the Pashtun population of Khyber Pakhtunkhwa, Pakistan.ConclusionAll the three selected SNPs of BRCA1, BRCA2 and TP53 showed significant association with breast cancer risk in the Pashtun population of Khyber Pakhtunkhwa, Pakistan. However, more investigation will be required on large data sets to confirm the selected SNPs and other SNPs in the selected and other related genes with the risk of breast cancer.
引用
收藏
页码:6087 / 6096
页数:10
相关论文
共 50 条
  • [41] Assessment of HER1 (rs11543848) and HER2 (rs1136201) polymorphism and their association with colorectal cancer susceptibility in Khyber Pakhtunkhwa, Pakistan
    Ullah, Asad
    Khan, Bibi Maryam
    Khan, Najeeb Ullah
    Muntaha, Sidra Tul
    Khan, Samiullah
    Khan, Aakif Ullah
    Almutairi, Mikhlid H.
    Ali, Ijaz
    MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
  • [42] The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers
    Catucci, Irene
    Verderio, Paolo
    Pizzamiglio, Sara
    Manoukian, Siranoush
    Peissel, Bernard
    Zaffaroni, Daniela
    Roversi, Gaia
    Ripamonti, Carla B.
    Pasini, Barbara
    Barile, Monica
    Viel, Alessandra
    Giannini, Giuseppe
    Papi, Laura
    Varesco, Liliana
    Martayan, Aline
    Riboni, Mirko
    Volorio, Sara
    Radice, Paolo
    Peterlongo, Paolo
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (03) : 855 - 860
  • [43] Genotype Misclassification in Genetic Association Studies of the rs1042522 TP53 (Arg72Pro) Polymorphism: A Systematic Review of Studies of Breast, Lung, Colorectal, Ovarian, and Endometrial Cancer
    Dahabreh, Issa J.
    Schmid, Christopher H.
    Lau, Joseph
    Varvarigou, Vasileia
    Murray, Samuel
    Trikalinos, Thomas A.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2013, 177 (12) : 1317 - 1325
  • [44] Association Analysis of TP53 rs1042522, MDM2 rs2279744, rs3730485, MDM4 rs4245739 Variants and Acute Myeloid Leukemia Susceptibility, Risk Stratification Scores, and Clinical Features: An Exploratory Study
    Tripon, Florin
    Iancu, Mihaela
    Trifa, Adrian
    Crauciuc, George Andrei
    Boglis, Alina
    Balla, Beata
    Cosma, Adriana
    Dima, Delia
    Candea, Marcela
    Lazar, Erzsebet
    Jimbu, Laura
    Banescu, Claudia
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06)
  • [45] Beyond BRCA1 and BRCA2 wild-type breast and/or ovarian cancer families: germline mutations in TP53 and PTEN
    Blanco, A.
    Grana, B.
    Fachal, L.
    Santamarina, M.
    Cameselle-Teijeiro, J.
    Ruiz-Ponte, C.
    Carracedo, A.
    Vega, A.
    CLINICAL GENETICS, 2010, 77 (02) : 193 - 196
  • [46] Genetic polymorphisms of TP53 (rs1042522) and MDM2 (rs2279744) and colorectal cancer risk: An updated meta-analysis based on 59 case-control studies
    Elshazli, Rami M.
    Toraih, Eman A.
    Elgaml, Abdelaziz
    Kandil, Emad
    Fawzy, Manal S.
    GENE, 2020, 734
  • [47] Prevalence of the variant allele rs61764370 T>G in the 3′UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer families
    Antoinette Hollestelle
    Cory Pelletier
    Maartje Hooning
    Ellen Crepin
    Mieke Schutte
    Maxime Look
    J. Margriet Collee
    Anja Nieuwlaat
    Lambert C. J. Dorssers
    Caroline Seynaeve
    Yurii S. Aulchenko
    John W. M. Martens
    Ans M. W. van den Ouweland
    Joanne B. Weidhaas
    Breast Cancer Research and Treatment, 2011, 128 : 79 - 84
  • [48] The functional BRCA1 rs799917 genetic polymorphism is associated with gastric cancer risk in a Chinese Han population
    Wang, Kun
    Xu, Longfang
    Pan, Lin
    Xu, Kesen
    Li, Guixia
    TUMOR BIOLOGY, 2015, 36 (01) : 393 - 397
  • [49] The rate of recurrent BRCA1, BRCA2, and TP53 mutations in the general population, and unselected ovarian cancer cases, in Belo Horizonte, Brazil
    Schayek, Hagit
    De Marco, Luiz
    Starinsky-Elbaz, Sigal
    Rossette, Mariana
    Laitman, Yael
    Bastos-Rodrigues, Luciana
    da Silva Filho, Agnaldo Lopes
    Friedman, Eitan
    CANCER GENETICS, 2016, 209 (1-2) : 50 - 52
  • [50] TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations:: Distinctive spectrum and structural distribution
    Greenblatt, MS
    Chappuis, PO
    Bond, JP
    Hamel, N
    Foulkes, WD
    CANCER RESEARCH, 2001, 61 (10) : 4092 - 4097